Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens

Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens

Abstract High‐throughput metabolic fingerprinting has been deemed one of the most promising strategies for addressing the high false positive rate of prostate cancer (PCa) diagnosis in the prostate‐specific antigen (PSA) gray zone. However, the current metabolic fingerprinting remains challenging in...

Full description

Bibliographic Details
Main Authors: Shaowei Xie, Xiaochen Fei, Jiayi Wang, Yi‐Cheng Zhu, Jiazhou Liu, Xinxing Du, Xuesong Liu, Liang Dong, Yinjie Zhu, Jiahua Pan, Baijun Dong, Jianjun Sha, Yu Luo, Wenshe Sun, Wei Xue
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Advanced Science
Subjects:
MoS2/MXene
noninvasive
prostate cancer
self‐assembly
urinary metabolic fingerprinting
Online Access:https://doi.org/10.1002/advs.202206494

Internet

https://doi.org/10.1002/advs.202206494

Similar Items